Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-drma
/
Dermata Therapeutics Inc
DRMA
7.060
USD
+0.610
+9.46%
Close 08/04, 16:00(ET)
Quotes delayed by 15 min
7.060
USD
+7.060
After-hours (ET)
42.59M
Market Cap
Loss
P/E TTM
Dermata Therapeutics Inc
7.060
+0.610
+9.46%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Total equity
Cash, cash equivalents and short-term investments
105.32%
9.72M
-57.50%
3.16M
-7.35%
6.14M
-41.37%
4.95M
-46.00%
4.73M
19.18%
7.44M
-17.79%
6.63M
-20.60%
8.44M
7.03%
8.77M
-42.20%
6.24M
-35.99%
8.07M
2387.79%
10.63M
515.67%
8.19M
--
10.80M
--
12.60M
--
427.20K
--
1.33M
- Cash and cash equivalents
105.32%
9.72M
-57.50%
3.16M
-7.35%
6.14M
-41.37%
4.95M
-46.00%
4.73M
19.18%
7.44M
-17.79%
6.63M
-20.60%
8.44M
7.03%
8.77M
-42.20%
6.24M
-35.99%
8.07M
2387.79%
10.63M
515.67%
8.19M
--
10.80M
--
12.60M
--
427.20K
--
1.33M
Receivables
--
--
--
--
--
--
--
--
--
--
-33.69%
8.36K
-99.41%
76.00
--
790.00
--
6.36K
--
12.60K
--
12.89K
--
--
--
--
--
--
--
--
--
--
--
--
-Other receivables
--
--
--
--
--
--
--
--
--
--
-33.69%
8.36K
-99.41%
76.00
--
790.00
--
6.36K
--
12.60K
--
12.89K
--
--
--
--
--
--
--
--
--
--
--
--
Prepaid expenses
-35.94%
285.74K
-30.03%
372.32K
-21.43%
543.59K
-36.87%
172.70K
-14.54%
446.07K
-22.94%
532.14K
-22.72%
691.82K
-31.36%
273.56K
-22.49%
521.99K
-10.24%
690.59K
-17.30%
895.17K
1684.47%
398.54K
1477.39%
673.47K
--
769.42K
--
1.08M
--
22.33K
--
42.70K
Other current assets
--
--
--
--
--
--
--
116.75K
--
--
--
--
--
--
--
--
--
--
-100.00%
0.00
--
0.00
-100.00%
0.00
-35.42%
179.59K
--
55.72K
--
--
--
687.33K
--
278.07K
Total current assets
93.16%
10.01M
-55.71%
3.53M
-8.69%
6.69M
-39.90%
5.24M
-44.27%
5.18M
14.89%
7.98M
-18.40%
7.32M
-20.98%
8.71M
2.78%
9.30M
-40.26%
6.94M
-34.42%
8.97M
869.90%
11.03M
447.73%
9.04M
--
11.62M
--
13.69M
--
1.14M
--
1.65M
Non-current assets
Net Fixed Assets
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00
--
0.00
--
0.00
-Fixed Assets
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
76.61K
--
76.61K
--
76.61K
-Accumulated depreciation
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
76.61K
--
76.61K
--
76.61K
Total non-current assets
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00
--
0.00
--
0.00
Total assets
93.16%
10.01M
-55.71%
3.53M
-8.69%
6.69M
-39.90%
5.24M
-44.27%
5.18M
14.89%
7.98M
-18.40%
7.32M
-20.98%
8.71M
2.78%
9.30M
-40.26%
6.94M
-34.42%
8.97M
869.90%
11.03M
447.73%
9.04M
--
11.62M
--
13.69M
--
1.14M
--
1.65M
Liabilities
Current liabilities
-Other payables
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
-100.00%
0.00
-100.00%
0.00
--
--
--
0.00
--
4.94K
--
3.19K
Accrued expenses
138.24%
1.31M
53.75%
1.16M
144.72%
1.08M
141.24%
591.25K
-23.10%
549.22K
77.87%
757.59K
-56.66%
442.36K
-67.65%
245.08K
34.93%
714.16K
-57.47%
425.93K
139.93%
1.02M
30.28%
757.66K
93.78%
529.27K
--
1.00M
--
425.37K
--
581.58K
--
273.13K
Short-term debt and lease liabilities
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
-100.00%
0.00
-100.00%
0.00
--
0.00
--
0.00
--
174.84K
--
174.77K
-Short-term debt
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00
--
0.00
--
174.84K
--
174.77K
Other current liabilities
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
-100.00%
0.00
-100.00%
0.00
--
--
--
0.00
--
4.94K
--
3.19K
Total current liabilities
97.10%
2.70M
21.51%
1.97M
112.27%
1.95M
180.94%
1.92M
13.65%
1.37M
75.98%
1.62M
-39.05%
916.82K
-50.03%
682.86K
1.30%
1.21M
-39.17%
922.63K
25.86%
1.50M
-16.81%
1.37M
26.87%
1.19M
--
1.52M
--
1.20M
--
1.64M
--
939.18K
Non-current liabilities
Long-term debt and lease liabilities
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
-Long-term debt
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
--
--
--
--
--
--
0.00
Other non-current liabilities
--
0.00
--
--
--
--
--
--
--
--
--
--
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
--
--
--
--
--
--
--
Total non-current liabilities
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
0.00
--
--
--
--
--
--
--
0.00
Total liabilities
97.10%
2.70M
21.51%
1.97M
112.27%
1.95M
180.94%
1.92M
13.65%
1.37M
75.98%
1.62M
-39.05%
916.82K
-50.03%
682.86K
1.30%
1.21M
-39.17%
922.63K
25.86%
1.50M
-16.81%
1.37M
26.87%
1.19M
--
1.52M
--
1.20M
--
1.64M
--
939.18K
Shareholders' equity
Common equity
24.78%
75.28M
12.54%
67.24M
16.66%
67.27M
8.87%
62.67M
7.88%
60.33M
15.75%
59.74M
12.19%
57.66M
12.52%
57.56M
19.95%
55.92M
11.99%
51.62M
11.92%
51.39M
63.95%
51.16M
49.96%
46.62M
--
46.09M
--
45.92M
--
31.20M
--
31.09M
Retained earnings
-20.27%
-67.98M
-23.02%
-65.68M
-21.99%
-62.52M
-19.82%
-59.35M
-18.16%
-56.52M
-17.10%
-53.39M
-16.69%
-51.25M
-19.36%
-49.53M
-23.38%
-47.83M
-26.71%
-45.59M
-31.39%
-43.92M
-30.84%
-41.50M
-27.59%
-38.77M
--
-35.98M
--
-33.43M
--
-31.72M
--
-30.38M
Capital reserves
24.78%
75.28M
12.54%
67.24M
16.66%
67.27M
8.87%
62.67M
7.88%
60.33M
15.75%
59.74M
12.19%
57.66M
12.52%
57.56M
19.95%
55.92M
11.99%
51.61M
11.92%
51.39M
63.95%
51.16M
49.96%
46.62M
--
46.09M
--
45.92M
--
31.20M
--
31.09M
Total equity
91.73%
7.30M
-75.44%
1.56M
-25.99%
4.74M
-58.68%
3.32M
-52.92%
3.81M
5.53%
6.36M
-14.24%
6.41M
-16.87%
8.03M
3.00%
8.09M
-40.42%
6.02M
-40.19%
7.47M
2009.83%
9.66M
1002.88%
7.85M
--
10.11M
--
12.49M
--
-505.80K
--
712.00K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up